NASDAQ:PHIO
Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp. reported net income of −$8.7M in fiscal 2025. Free cash flow was −$8.0M.Summary generated from Phio Pharmaceuticals Corp.'s SEC filings. Latest annual report filed Mar 5, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−69.9%
Debt / equityn/a
Free cash flow−$8.0M
FCF marginn/a
Share count changen/a
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a |
| Operating income | −14 | −11 | −11 | −7 | −9 |
| Net income | −13 | −11 | −11 | −7 | −9 |
| Free cash flow | −12 | −12 | −11 | −7 | −8 |
Recent filings
- 4Insider transaction report
Sep 30, 2026 - 4Insider transaction report
Sep 29, 2026 - 8-KDirector or officer change
Sep 28, 2026 - 8-KOther events
Sep 14, 2026 - DEF 14AProxy statement
Aug 14, 2026 - 8-KResults of operations and financial condition
Aug 6, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 6, 2026 - 8-KDirector or officer change
Jul 21, 2026